Pediatrix Medical Group, Inc.

MD Healthcare Medical Care Facilities

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.

27.38 0.38 −1.37%
Market cap
$2.3B
P/E
13.1×
Fwd P/E
11.3×
Dividend yield
—
F-score
7/9
Altman Z
2.05
Beneish M
−2.86
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

19.98% 20.28% 20.89% 20.39%
Piotroski F-Score
7 7 8 7
ROA
7.59% 7.52% 8.57% 8.26%
ROIC
12.09% 13.55% 11.97% 12.69%
Return on Tangible Assets
44.64% 48.11% 93.93% 88.61%
Average Days of Receivables
44.61 46.21 44.78 44.72
Free Cash Flow per Share
3.23 3.00 2.93 2.88
Free Cash Flow
273.39 252.63 237.32 228.61
Capital Expenditures
(16.61) (18.46) (21.39) (18.25)
Other line items
Cash ROIC
13.97% 12.87% 13.20% 12.23%
Accounts Receivable Turnover
7.35 7.43 7.89 8.03
Accounts Payable Turnover
4.16 3.47 6.06 4.76
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
90.15 107.83 60.57 76.57
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.21) (0.24) (0.23) (0.23)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
12.41% 12.58% 12.55% 12.72%
Share Based Compensation of Revenue
0.80% 0.94% 0.99% 1.04%
Interest Coverage
5.40 5.81 6.23 6.31
Operating CF/Net income
1.79 1.64 1.48 1.41
Depreciation/Fixed assets
0.62 0.58 0.57 0.61
Capex/Depreciation
(0.69) (0.81) (0.91) (0.77)
Revenue per Share
22.72 22.76 23.88 24.55
Operating CF per Share
3.43 3.22 3.20 3.11
Capex per Share
(0.20) (0.22) (0.26) (0.23)
Capex to Sales
0.01 0.01 0.01 0.01

Fold the line items

Columns are period end dates